Live from the NIH registry
Studies recruiting near Bridgeport right now
Top 25 of 1,479 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — New Haven, Connecticut (16.0 mi)
· Sponsor: Medtronic
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Stony Brook University Medical Center — Stony Brook, New York (18.6 mi)
· Sponsor: Syndax Pharmaceuticals
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Yale Cancer Center — New Haven, Connecticut (16.0 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Yale University — New Haven, Connecticut (16.0 mi)
· Sponsor: National Cancer Institute (NCI)
Definitive Radiation for High-Risk Spine Metastases
Metastatic Cancer, Metastatic Lung Cancer
Phase 2
Interventional 26 participants sought
Stony Brook University Hospital — Stony Brook, New York (18.6 mi)
· Sponsor: Stony Brook University
Speech Motor Learning and Retention (Aim 3)
Speech
N/A
Interventional 50 participants sought
Yale Child Study Center — New Haven, Connecticut (16.0 mi)
· Sponsor: Yale University
Opioid Sparing Effect of an ISP Nerve Block on Post-Op Pain Control in Posterior Cervical Spine Surgery
Pain, Postoperative
N/A
Interventional 60 participants sought
Stony Brook University Hospital — Stony Brook, New York (18.6 mi)
· Sponsor: Stony Brook University
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Graft Versus Host Disease, Graft Vs Host Disease
Phase 2
Interventional 46 participants sought
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — New Haven, Connecticut (16.0 mi)
· Sponsor: Normunity AccelCo, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Yale University School of Medicine — New Haven, Connecticut (16.0 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0117 — New Haven, Connecticut (16.0 mi)
· Sponsor: Bristol-Myers Squibb
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (21.0 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery
Brain Metastasases
Phase 2
Interventional 50 participants sought
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Yale University (Adults and Pediatrics) — New Haven, Connecticut (16.0 mi)
· Sponsor: Pierre Fabre Medicament
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Smilow Cancer Hospital Care Center-Trumbull — Trumbull, Connecticut (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — New Haven, Connecticut (16.0 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Smilow Cancer Hospital (Yale University) — New Haven, Connecticut (16.0 mi)
· Sponsor: Revolution Medicines, Inc.
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Yale School Of Medicine — New Haven, Connecticut (16.0 mi)
· Sponsor: Takeda
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma
Phase 2
Interventional 134 participants sought
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Open Surgery, Lymphedema
N/A
Observational 455 participants sought
Yale New Haven Hospital — New Haven, Connecticut (16.0 mi)
· Sponsor: MMI (Medical Microinstruments, Inc.)
A Study of Hospital-at-Home for People Receiving Tarlatamab
Small-cell Lung Cancer, Small Cell Lung Carcinoma
N/A
Interventional 70 participants sought
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) — Commack, New York (24.6 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nuvance Health Danbury Hospital — Danbury, Connecticut (19.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
New England Institute for Clinical Research (Ki Health Partners) — Stamford, Connecticut (20.3 mi)
· Sponsor: Annovis Bio Inc.
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Opioid Use Disorder, OAT
Phase 1
Interventional 110 participants sought
Connecticut Mental Health Center, Clinical Neuroscience Research Unit — New Haven, Connecticut (16.0 mi)
· Sponsor: Yale University
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Primary Progressive Multiple Sclerosis, Primary Progressive MS
Phase 2
Interventional 20 participants sought
Local Institution - Site 106 — Stony Brook, New York (18.6 mi)
· Sponsor: Sundance Biosciences, Inc.